












Yongjin Park
Founder at 1849 bio
I am the co-founder and CSO of 1849 bio. I studied chemical engineering at KAIST and did my PhD at MIT in the Department of Biological Engineering. During my PhD, I developed core technology used in the world's first engineered probiotic that went into clinical trial. After completing PhD, I worked in deep biotech companies, developing microbial products that were administered to over 6M acres of farmland in the US (about the area of Belgium!).
Follow Yongjin
Previously at

Pivot Bio

Empress Therapeutics

Zymergen

Massachusetts Institute of Technology (MIT)
Alumnus of
Massachussetts Institute of Technology (MIT)

Korea Advanced Institute of Science and Technology